Neuronetics (STIM) Cash & Current Investments (2017 - 2026)

Neuronetics (STIM) has reported Cash & Current Investments for 10 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Current Investments rose 200.35% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $6.0 million (up 200.35% YoY), while the FY2025 annual figure was $6.2 million, up 416.17% from the prior year.
• Cash & Current Investments eased to $6.0 million in Q1 2026 per STIM's latest filing, from $6.2 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $83.0 million in Q1 2022 and bottomed at $1.2 million in Q4 2024.
• Historically, Cash & Current Investments has averaged $38.3 million across 5 years, with a median of $43.3 million in 2024.
• Annual changes were most pronounced in 2024 — Cash & Current Investments tumbled 98.01% — and 2025, when it soared 416.17%.
• Neuronetics' Cash & Current Investments stood at $71.9 million in 2022, then declined by 15.72% to $60.6 million in 2023, then sank by 98.01% to $1.2 million in 2024, then jumped by 416.17% to $6.2 million in 2025, then decreased by 3.5% to $6.0 million in 2026.
• Business Quant data shows STIM's Cash & Current Investments at $6.0 million in Q1 2026, $6.2 million in Q4 2025, and $6.7 million in Q3 2025.